Brazil's Braskem shares surge on prospects of tax incentive bill backing petrochemical sector

Braskem shares surged over 7% after Brazil's Chamber of Deputies advanced an urgency regime for Bill 892/2025, the PRESIQ program, which proposes significant tax incentives for the petrochemical sector. This legislative development is projected to boost Braskem's annual EBITDA by up to US$500 million by 2026, representing a roughly 40% increase over current 2025 projections, and is expected to enhance its credit profile. While the bill still requires full congressional approval, its swift progression signals strong government support for the industry and has driven investor confidence in Braskem's potential for improved profitability and debt alleviation.

Analysis

Braskem S.A. (BAK) has experienced a significant positive catalyst following the advancement of Bill 892/2025 in Brazil's Congress, which propelled its shares over 7%. The proposed PRESIQ program represents a material inflection point for the company's fundamentals, with analyst projections indicating a potential annual EBITDA uplift of up to US$500 million by 2026. This figure constitutes a roughly 40% increase relative to current 2025 forecasts and would be a substantial tailwind for a company that has recently contended with low demand and high raw material costs. Furthermore, the expected tax incentives are anticipated to directly improve Braskem's credit profile and alleviate pressure on its debt structure, according to insights from Bradesco BBI. While the market's reaction signals strong confidence, a key risk remains as the bill has not yet passed into law and is subject to further votes and potential amendments in both the House and Senate. The legislative urgency, however, suggests strong political will to support the domestic petrochemical industry, positioning Braskem as a primary beneficiary if the measure is enacted.

Key Decisions for Investors

• The potential for a 40% increase in EBITDA presents a compelling valuation re-rating catalyst, warranting consideration for initiating or increasing positions for investors with an appetite for event-driven and legislative-risk scenarios.
• Investors must closely monitor the legislative progress of Bill 892/2025, as any delays, adverse amendments, or failure to pass would likely trigger a sharp reversal of the recent share price gains.
• Beyond the immediate catalyst, the bill signals a broader policy shift towards supporting Brazil's industrial base, suggesting a potential long-term structural improvement in the operating environment for Braskem against global competition and cost pressures.